{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:40:51Z","timestamp":1783654851844,"version":"3.55.0"},"reference-count":25,"publisher":"e-Century Publishing Corporation","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/bsyz7959","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T04:40:59Z","timestamp":1740544859000},"page":"643-651","source":"Crossref","is-referenced-by-count":3,"title":["Comparative study between single modality radiotherapy and concurrent chemoradiation for selected patients with early-stage laryngeal cancer"],"prefix":"10.62347","volume":"15","author":[{"given":"Fatma","family":"Gharib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","unstructured":"Global Cancer Observatory. International Agency for Research on Cancer. World Health Organization. Available at: https:\/\/gco.iarc.fr\/(Accessed on June 06, 2021)."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.mlg.0000236095.97947.26","article-title":"Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival","volume":"116","author":"Hoffman","year":"2006","unstructured":"Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A and Robinson RA. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 1-13.","journal-title":"Laryngoscope"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/0194599815574254","article-title":"The anatomic distribution of malignant and premalignant glottic lesions and its relations to smoking","volume":"152","author":"Shoffel-Havakuk","year":"2015","unstructured":"Shoffel-Havakuk H, Halperin D, Yosef L, Haimovich Y and Lahav Y. The anatomic distribution of malignant and premalignant glottic lesions and its relations to smoking. Otolaryngol Head Neck Surg 2015; 152: 678-83.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1200\/JOP.2017.027912","article-title":"Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary","volume":"14","author":"AA","year":"2018","unstructured":"Forastiere AA, Ismaila N and Wolf GT. Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary. J Oncol Pract 2018; 14: 123-128.","journal-title":"J Oncol Pract"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/hed.25582","article-title":"Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: results after 1 year","volume":"41","author":"Loon Y","year":"2019","unstructured":"van Loon Y, Hendriksma M, Heijnen BJ, van de Kamp VAH, Hakkesteegt MM, Böhringer S, Langeveld TPM, de Jong MA, Klop WMC, Baatenburg de Jong RJ and Sjögren EV. Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: results after 1 year. Head Neck 2019; 41: 1638-1647.","journal-title":"Head Neck"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"DS","year":"2022","unstructured":"Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D’Amico TA, DeCamp M, Dilling TJ, Dowell J, Gettinger S, Grotz TE, Gubens MA, Hegde A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Ng T, Otterson GA, Pacheco JM, Patel SP, Riely GJ, Riess J, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory K and Hughes M. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2022; 20: 497-530.","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"11900","DOI":"10.1038\/s41598-018-30218-x","article-title":"Comparison between transoral laser surgery and radiotherapy in the treatment of early glottic cancer: a systematic review and meta-analysis","volume":"8","author":"Guimar&#xE3","year":"2018","unstructured":"Guimarães AV, Dedivitis RA, Matos LL, Aires FT and Cernea CR. Comparison between transoral laser surgery and radiotherapy in the treatment of early glottic cancer: a systematic review and meta-analysis. Sci Rep 2018; 8: 11900.","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/MOO.0000000000000438","article-title":"Oncologic and functional outcomes of patients treated with transoral CO2 laser microsurgery or radiotherapy for T2 glottic carcinoma: a systematic review of the literature","volume":"26","author":"Hendriksma","year":"2018","unstructured":"Hendriksma M, Heijnen BJ and Sjogren EV. Oncologic and functional outcomes of patients treated with transoral CO2 laser microsurgery or radiotherapy for T2 glottic carcinoma: a systematic review of the literature. Curr Opin Otolaryngol Head Neck Surg 2018; 26: 84-93.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Campo F, Zocchi J, Ralli M, De Seta D, Russo FY, Angeletti D, Minni A, Greco A, Pellini R and de Vincentiis M. Laser microsurgery versus radiotherapy versus open partial laryngectomy for T2 laryngeal carcinoma: a systematic review of oncological outcomes. Ear Nose Throat J 2021; 100: 51S-58S.","DOI":"10.1177\/0145561320928198"},{"key":"ref9","unstructured":"Du G, Liu C, Yu W, Li J, Li W, Wang C and Zhu J. Voice outcomes after laser surgery vs. radiotherapy of early glottic carcinoma: a meta-analysis. Int J Clin Exp Med 2015; 8: 17206-13."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40463-018-0321-8","article-title":"Functional outcomes in early (T1\/T2) supraglottic cancer: a systematic review","volume":"47","author":"van der Woerd","year":"2018","unstructured":"van der Woerd B, Patel KB, Nichols AC, Fung K, Yoo J and MacNeil SD. Functional outcomes in early (T1\/T2) supraglottic cancer: a systematic review. J Otolaryngol Head Neck Surg 2018; 47: 76","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10103-016-2103-8","article-title":"Transoral laser microsurgery versus radiotherapy for T1 glottic carcinoma: a systematic review and meta-analysis","volume":"32","author":"HL","year":"2017","unstructured":"Mo HL, Li J, Yang X, Zhang F, Xiong JW, Yang ZL, Tan J and Li B. Transoral laser microsurgery versus radiotherapy for T1 glottic carcinoma: a systematic review and meta-analysis. Lasers Med Sci 2017; 32: 461-467.","journal-title":"Lasers Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/coa.12790","article-title":"Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes","volume":"42","author":"Warner","year":"2017","unstructured":"Warner L, Lee K and Homer JJ. Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes. Clin Otolaryngol 2017; 42: 629-636.","journal-title":"Clin Otolaryngol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1200\/JCO.2006.07.4559","article-title":"American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer","volume":"24","author":"Society of Clinical Oncology","year":"2006","unstructured":"American Society of Clinical Oncology; Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, Clayman GL, Fisher SG, Forastiere AA, Harrison LB, Lefebvre JL, Leupold N, List MA, O’Malley BO, Patel S, Posner MR, Schwartz MA and Wolf GT. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006; 24: 3693-704.","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1748-717X-7-193","article-title":"Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20-year Cleveland clinic experience","volume":"7","author":"Khan","year":"2012","unstructured":"Khan MK, Koyfman SA, Hunter GK, Reddy CA and Saxton JP. Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20-year Cleveland clinic experience. Radiat Oncol 2012; 7: 193.","journal-title":"Radiat Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ijrobp.2007.05.077","article-title":"Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience","volume":"69","author":"Reddy","year":"2007","unstructured":"Reddy SP, Hong RL, Nagda S and Emami B. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. Int J Radiat Oncol Biol Phys 2007; 69: 1389-94.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ijrobp.2014.04.041","article-title":"Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)","volume":"89","author":"A 3rd","year":"2014","unstructured":"Trotti A 3rd, Zhang Q, Bentzen SM, Emami B, Hammond ME, Jones CU, Morrison WH, Sagar SM, Ridge JA, Fu KK and Ang KK. Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512). Int J Radiat Oncol Biol Phys 2014; 89: 958-963.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ijrobp.2005.10.003","article-title":"Radiation therapy for T2N0 laryngeal cancer: a retrospective analysis for the impact of concurrent chemotherapy on local control","volume":"64","author":"Akimoto","year":"2006","unstructured":"Akimoto T, Nonaka T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K, Furuya N, Hayakawa K, Mitsuhashi N and Nakano T. Radiation therapy for T2N0 laryngeal cancer: a retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys 2006; 64: 995-1001.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref18","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: head and neck cancers. NCCN Org: Version, 2. (2018) CRID: 1572824500572420352. NII Article ID. 10024434421 http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/occult.pdf"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/hed.27165","article-title":"Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapy","volume":"44","author":"de Leo","year":"2022","unstructured":"de Leo AN, Dagan R, Morris CG, Holtzman AL, Hitchcock KE, Bryant CM, Amdur RJ and Mendenhall WM. Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapy. Head Neck 2022; 44: 2513-2521.","journal-title":"Head Neck"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1748-717X-7-122","article-title":"Multi-institutional analysis of early glottic cancer from 2000 to 2005","volume":"7","author":"Hirasawa","year":"2012","unstructured":"Hirasawa N, Itoh Y, Naganawa S, Ishihara S, Suzuki K, Koyama K, Murao T, Asano A, Nomoto Y, Horikawa Y, Sasaoka M and Obata Y. Multi-institutional analysis of early glottic cancer from 2000 to 2005. Radiat Oncol 2012; 7: 122.","journal-title":"Radiat Oncol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/hed.24520","article-title":"Impaired vocal cord mobility in T2N0 glottic carcinoma: suboptimal local control with radiation alone","volume":"38","author":"Bhateja","year":"2016","unstructured":"Bhateja P, Ward MC, Hunter GH, Greskovich JF, Reddy CA, Nwizu TI, Lamarre E, Burkey BB, Adelstein DJ and Koyfman SA. Impaired vocal cord mobility in T2N0 glottic carcinoma: suboptimal local control with radiation alone. Head Neck 2016; 38: 1832-1836.","journal-title":"Head Neck"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.radonc.2013.09.016","article-title":"A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study","volume":"110","author":"Moon","year":"2014","unstructured":"Moon SH, Cho KH, Chung EJ, Lee CG, Lee KC, Chai GY, Kang KM, Lee JY, Chung WK, Park WY and Kim JH. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study. Radiother Oncol 2014; 110: 98-103.","journal-title":"Radiother Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","unstructured":"Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, Bentzen J, Bastholt L, Hansen O, Johansen J, Andersen L and Evensen JF. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003; 362: 933-40.","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.radonc.2015.07.004","article-title":"The DAHANCA 6 randomized trial: effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma","volume":"117","author":"Lyhne","year":"2015","unstructured":"Lyhne NM, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Evensen J, Mortensen HR and Overgaard J. The DAHANCA 6 randomized trial: effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma. Radiother Oncol 2015; 117: 91-8.","journal-title":"Radiother Oncol"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/2\/ajcr0152006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:58:57Z","timestamp":1766023137000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/2\/ajcr0152006.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/bsyz7959","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}